4.9(top 3%)
Impact Factor
5.5(top 3%)
extended IF
231(top 1%)
H-Index
3.7K
authors
28.7K
papers
765.6K
citations
8.8K
citing journals
61.2K
citing authors

Most Cited Articles of American Journal of Ophthalmology

TitleYearCitations
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop20052.7K
Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus20032K
The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators20002K
New Visual Acuity Charts for Clinical Research19821.7K
Enhanced depth imaging spectral-domain optical coherence tomography20081.6K
Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group19981.2K
Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy19941.1K
A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes20091K
The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group19981K
Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma1989896
A role for local inflammation in the formation of drusen in the aging eye2002872
Prevalence of dry eye syndrome among US women2003856
Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group1984833
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 22001825
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration2007806
Excimer laser surgery of the cornea1983784
Trabeculectomy1968750
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel2000711
The epidemiology of age-related macular degeneration2004702
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study2009691
Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group1976662
Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders1994659
A 48-year clinical and epidemiologic study of keratoconus1986658
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 12008651
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up2012643